Back to top

Image: Shutterstock

Top Ranked Value Stocks to Buy for February 23rd

Read MoreHide Full Article

Here are four stocks with buy rank and strong value characteristics for investors to consider today, February 23rd:

Century Communities, Inc. (CCS - Free Report) : This single-family attached and detached homes developer has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 38.2% over the last 60 days.

 

Century Communities has a price-to-earnings ratio (P/E) of 6.99, compared with 12.60 for the industry. The company possesses a Value Score of A.

 

Customers Bancorp, Inc. (CUBI - Free Report) : This bank holding company has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 16.6% over the last 60 days.

 

Customers Bancorp has a price-to-earnings ratio (P/E) of 5.39, compared with 12.90 for the industry. The company possesses a Value Score of A.

 

BGC Partners, Inc. : This brokerage and financial technology company has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 1.8% over the last 60 days.

 

BGC Partners has a price-to-earnings ratio (P/E) of 6.92, compared with 16.10 for the industry. The company possesses a Value Score of A.

 

BGC Partners, Inc. PE Ratio (TTM)

BGC Partners, Inc. PE Ratio (TTM)

BGC Partners, Inc. pe-ratio-ttm | BGC Partners, Inc. Quote

 

Taylor Morrison Home Corporation (TMHC - Free Report) : This public homebuilding company has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising nearly 15% over the last 60 days.

 

Taylor Morrison Home has a price-to-earnings ratio (P/E) of 6.12, compared with 12.60 for the industry. The company possesses a Value Score of A.

 

See the full list of top ranked stocks here.

Learn more about the Value score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Century Communities, Inc. (CCS) - free report >>

Taylor Morrison Home Corporation (TMHC) - free report >>

Customers Bancorp, Inc (CUBI) - free report >>

Published in